FDA Approved: ROFLUMILAST — Supplemental Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' supplemental ANDA for roflumilast (generic roflumilast), expanding access to this COPD treatment as a generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

SUPPL AP for ROFLUMILAST (ROFLUMILAST)